Gabriella Karefa-Johnson has quietly wiped her job title from her Instagram account after unleashing a rant in which she likened Israel to an “apartheid state” committing “genocid…
‘Deeply disgusted’ Cornell students call for action against prof who was ‘exhilarated’ by Hamas attackVogue contributing editor-at-large Gabriella Karefa-Johnson has quietly wiped her job title from her Instagram account after unleashing a rant in which she likened Israel to an “apartheid state” committing “genocide” and compared the Israeli Defense Forces to a “terrorist organization.”
A source close to the situation emphasized that Karefa-Johnson is not a full-time employee at the Anna Wintour-run glossy, adding that the stylist was not instructed by anyone at Condé Nast to scrub her editor title from her Instagram profile. The stylist, who has also worked for brands like Calvin Klein, Suart Weitzman, Joseph Altuzarra and retailer Target, questioning how people could say “I stand with Israel” while continued strikes hammered Gaza, following Hamas’ refusal to return the hostages.“I cannot believe that the world is watching in silence as a GENOCIDE — a mass Palestinian extinction plan — is happening before our very eyes,” she continued. “These are WAR CRIMES.
Karefa-Johnson hit back, saying she never denied that Israelis were murdered but that the number of Israelis harmed was “far less” than the number of Palestinians in the retaliation.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Bank of America reports, Johnson & Johnson, retail sales: 3 things to watchBank of America reports, Johnson & Johnson, retail sales: 3 things to watch
Baca lebih lajut »
Johnson & Johnson Reports Earnings Tuesday. What to ExpectAn update in August after the split leaves investors with fewer questions for Tuesday's results.
Baca lebih lajut »
Johnson & Johnson earnings: What to expectJohnson & Johnson is not expected to produce big surprises in its earnings release due Tuesday
Baca lebih lajut »
Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surgeIt marks J&J’s first quarterly results since the company completed the separation from its consumer health spinoff Kenvue in August.
Baca lebih lajut »
Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surgeIt marks J&J’s first quarterly results since the company completed the separation from its consumer health spinoff Kenvue in August.
Baca lebih lajut »
Johnson & Johnson's stock climbs after company beats earnings estimates and raises profit guidanceJohnson & Johnson raised its full year EPS guidance and lifted the midpoint of its sales range
Baca lebih lajut »